Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase

被引：0

作者：

Castven, Darko ^{[1
]}

Keggenhoff, Friederike ^{[2
]}

Stojkovic, Stojan ^{[1
]}

Becker, Diana

Castven, Jovana ^{[1
]}

Zimpel, Carolin ^{[1
]}

Straub, Beate ^{[2
]}

Langer, Harald ^{[1
]}

Hahnel, Patrizia

Kindler, Thomas

Fahrer, Jörg ^{[3
]}

Rourke, Colm O. ^{[4
]}

Ma, Lichun ^{[5
]}

Wang, Xin W. ^{[5
]}

Gaiser, Timo ^{[6
]}

Matter, Matthias ^{[7
]}

Sina, Christian ^{[1
]}

Derer, Stefanie ^{[1
]}

Roessler, Stephanie ^{[8
]}

Kaina, Bernd ^{[2
]}

Andersen, Jesper ^{[4
]}

Galle, Peter ^{[2
]}

Marquardt, Jens ^{[1
]}

机构：

[1] Univ Klinikum Schleswig Holstein, Campus Lubeck, Lubeck, Germany

[2] Johannes Gutenberg Univ Mainz, Univ Med, Mainz, Germany

[3] Tech Univ Kaiserslautern, Kaiserslautern, Germany

[4] Biotech Res & Innovat Ctr, Copenhagen, Denmark

[5] NCI, NIH, Bethesda, MD USA

[6] Univ Med Mannheim, Mannheim, Germany

[7] Univ Spital Basel, Basel, Switzerland

[8] Heidelberg Univ, Heidelberg, Germany

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-230

引用

页码：S536 / S537

页数：2

共 50 条

[21] Radiosensitization of pancreatic cancer cells by combined inhibition of Chk1 and PARP1 using AZD7762 and olaparib
Vance, Sean M.
Maybuam, Jonathan
Lawrence, Theodore S.
Morgan, Meredith A.
CANCER RESEARCH, 2011, 71
[22] DNA repair and stemness determine the sensitizing effect of CHK1, RAD51 and PARP1 inhibition in TNBC
Meyer, F.
Becker, S.
Niecke, A.
Riepen, B.
Zielinski, A.
Werner, S.
Peitzsch, C.
Hein, L.
Dubrovska, A.
Wikmann, H.
Windhorst, S.
Goy, Y.
Parplys, A. C.
Petersen, C.
Rothkamm, K.
Borgmann, K.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S193 - S194
[23] Exploring the Synergy between PARP and CHK1 Inhibition in Matched BRCA2 Mutant and Corrected Cells
Smith, Hannah L.
Prendergast, Lisa
Curtin, Nicola J.
CANCERS, 2020, 12 (04)
[24] Further Studies on the Hypothesis of PARP-1 Inhibition as a Strategy for Lessening the Long-Term Effects Produced by Perinatal Asphyxia: Effects of Nicotinamide and Theophylline on PARP-1 Activity in Brain and Peripheral TissueNicotinamide and Theophylline on PARP-1 Activity
C. Allende-Castro
P. Espina-Marchant
D. Bustamante
E. Rojas-Mancilla
T. Neira
M. A. Gutierrez-Hernandez
D. Esmar
J. L. Valdes
P. Morales
P. J. Gebicke-Haerter
M. Herrera-Marschitz
Neurotoxicity Research, 2012, 22 : 79 - 90
[25] PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity
Caito, Samuel
Hwang, Jae-woong
Chung, Sangwoon
Yao, Hongwei
Sundar, Isaac K.
Rahman, Irfan
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 392 (03) : 264 - 270
[26] TAK-1 AND THIOREDOXIN METABOLISM INHIBITION: A POTENTIALLY POWERFUL COMBINATION THERAPY FOR KRAS-MUTATED COLON CANCERS
Hrabe, J.
Domann, F.
Spitz, D.
Mezhir, J.
DISEASES OF THE COLON & RECTUM, 2014, 57 (05) : E298 - E298
[27] Radiosensitization of HPV Positive Head and Neck Squamous Cell Carcinomas (HNSCC) by Chk1 Inhibition
Busch, C-J
Kriegs, M.
Laban, S.
Tribius, S.
Knecht, R.
Petersen, C.
Dikomey, E.
Rieckmann, T.
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 78 - 79
[28] TARGETING MYC/MYCN BY INHIBITION OF CHECKPOINT KINASE 1 (CHK1) SENSITIZES PAEDIATRIC GLIOBLASTOMA (PGBM) CELLS TO TEMOZOLOMIDE
Nandhabalan, Meera
Bjerke, Lynn
Vinci, Mara
Burford, Anna
Ingram, Wendy
Mackay, Alan
von Bueren, Andre
Baudis, Michael
Clarke, Paul
Collins, Ian
Workman, Paul
Jones, Chris
NEURO-ONCOLOGY, 2014, 16 : 49 - 49
[29] Reconstitution of Human Claspin-mediated Phosphorylation of Chk1 by the ATR (Ataxia Telangiectasia-mutated and Rad3-related) Checkpoint Kinase
Lindsey-Boltz, Laura A.
Sercin, Oezdemirhan
Choi, Jun-Hyuk
Sancar, Aziz
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (48) : 33107 - 33114
[30] Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition
Sarchi, Martina
Clough, Courtnee A.
Crosse, Edie I.
Kim, Jason
Galvis, Laura D. Baquero
Aydinyan, Nelli
Wellington, Rachel
Yang, Feini
Galli, Anna
Creamer, J. Philip
Stewart, Sintra
Bradley, Robert K.
Malcovati, Luca
Doulatov, Sergei
BLOOD CANCER DISCOVERY, 2024, 5 (05): : 353 - 370

← 1 2 3 4 5 →